234
Views
7
CrossRef citations to date
0
Altmetric
RPE and Choroid

Gender Differences in the Relationship between Sex Hormone Deficiency and Soft Drusen

, , , , ORCID Icon & ORCID Icon
Pages 1527-1536 | Received 12 Aug 2016, Accepted 24 May 2017, Published online: 14 Sep 2017

References

  • Leibowitz HM, Krueger DE, Maunder LR, Milton RC, Kini MM, Kahn HA, et al. The Framingham Eye Study monograph: an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973–1975. Surv Ophthalmol 1980;24:335–610.
  • Heiba IM, Elston RC, Klein BE, Klein R. Sibling correlations and segregation analysis of age-related maculopathy: the Beaver Dam eye study. Genet Epidemiol 1994;11:51–67.
  • Smith W, Assink J, Klein R, Mitchell P, Klaver CC, Klein BE, et al. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology 2001;108:697–704.
  • Vingerling JR, Dielemans I, Bots ML, Hofman A, Grobbee DE, de Jong PT, et al. Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study. Am J Epidemiol 1995;142:404–409.
  • Delcourt C, Cristol JP, Tessier F, Léger CL, Descomps B, Papoz L, et al. Age-related macular degeneration and antioxidant status in the POLA study. Pathologies Oculaires Liées a` l’Age. Arch Ophthalmol 1999;117:1384–1390.
  • Bird A. Age-related macular disease. Br J Ophthalmol 1996;80:2–3.
  • Curcio CA., Johnson M, Huang J-D, Rudolf M. Apolipoprotein B-containing lipoproteins in retinal aging and age-related macular degeneration. J Lipid Res 2010;51:451–467.
  • Rudnicka AR, Jarrar Z, Wormald R, Cook DG, Fletcher A, Owen CG. Age and gender variations in age-related macular degeneration prevalence in populations of European ancestry: a meta-analysis. Ophthalmology 2012;119:571–580.
  • Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1992;99:933–943.
  • Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 1995;102:1450–1460.
  • Vingerling JR, Dielemans I, Witteman JC, Hofman A, Grobbee DE, de Jong PT. Macular degeneration and early menopause: a case control study. BMJ 1995;310:1570–1571.
  • Connell PP, Keane PA, O’Neill EC, Altaie RW, Loane E, Neelam K. et al. Risk factors for age-related maculopathy. J Ophthalmol. 2009;2009: Article ID 360764. doi:10.1155/2009/360764.
  • Feskanich D, Cho E, Schaumberg DA, Colditz GA, Hankinson SE. Menopausal and reproductive factors and risk of age-related macular degeneration. Arch Ophthalmol 2008;126:519–524.
  • Cascio C, Deidda I, Russo D, Guarneri P. The estrogenic retina: the potential contribution to healthy aging and age-related neurodegenerative diseases of the retina. Steroids 2015;103:31–41.
  • The Eye Disease Case-Control Study Group: Risk factors for neovascular age-related macular degeneration. Arch Ophthalmol 1992;110:1701–1708.
  • Smith W, Mitchell P, Wang JJ. Gender, oestrogen, hormone replacement and age-related macular degeneration: results from the Blue Mountains Eye Study. Aust N Z J Ophthalmol 1997;25:S13–S15.
  • Harlow SD, Gass M, Hall JE, Lobo R, Maki P, Rebar RW, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Menopause 2012;19:387–395.
  • Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W, et al. Executive summary: stages of Reproductive Aging Workshop (STRAW) Park City, Utah, July, 2001. Menopause 2001;8:402–407.
  • Hari SGR Tunuguntla. Management of andropause: the male menopause. Clinical Geriatrics 2005;13:27–34.
  • The Practical Guide: Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. NHLBI Obesity Education Initiative 2000. NIH, National Heart, Lung, and Blood Institute: 2000:1–2.
  • What Do My Cholesterol Levels Mean? American Heart Association 2007; 6-22-2009.
  • Burtis CA, Ashwood ER, Bruns DE. Tietz Textbook of Clinical Chemistry and Molecular Diagnosis. 4th ed. St. Louis: Elsevier Saunders, 2006:731–805.
  • Kunisaki KM, Niewoehner DE, Connett JE. COPD Clinical Research Network. Vitamin D levels and risk of acute exacerbations of chronic obstructive pulmonary disease: a prospective cohort study. Am J Respir Crit Care Med 2012;185:286–290.
  • Araujo AB, O’Donnell AB, Brambilla DJ, Simpson WB, Longcope C, Matsumoto AM, et al. Prevalence and Incidence of Androgen Deficiency in Middle-Aged and Older Men: estimates from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 2004;89:5920–5926.
  • Minkin MJ, Wright CV. What Every Woman Needs to Know about Menopause: The Years Before, During, and After. Yale University Press, New Haven, CT. 1997. ISBN 0-300-07261-9.
  • Kato I, Toniolo P, Akhmedkhanov A, Koenig KL, Shore R, Zeleniuch-Jacquotte A. Prospective study of factors influencing the onset of natural menopause. J Clin Epidemiol 1998;51:1271–1276
  • Ringa, V. Menopause and treatments. Qual Life Res 2000;9:695–707.
  • Kaarniranta K, Machalinska A, Vereb Z, Salminen A, Petrovski G, Kauppinen A. Estrogen signalling in the pathogenesis of age-related maculardegeneration, Curr Eye Res 2015;40:226–233.
  • Moon BG, Joe SG, Hwang JU, Kim HK, Choe J, Yoon YH. Prevalence and risk factors of early-stage age-related macular degeneration in patients examined at a health promotion center in Korea. J Korean Med Sci 2012;27:537–541.
  • Pfeilschifter J, Köditz R, Pfohl M, Schatz H. Changes in proinflammatory cytokine activity after menopause. Endocr Rev 2002;23:90–119.
  • Tani A, Yasui T, Matsui S, et al. Different circulating levels of monocyte chemoattractant protein-1 and interleukin-8 during the menopausal transition. Cytokine 2013;62:86–90.
  • Anderson DH, Mullins RF, Hageman GS, Johnson LV. A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol 2002;134:411–431.
  • Cao S, Ko A, Partanen M, Pakzad-Vaezi K., Merkur AB, Albiani DA. et al. Relationship between systemic cytokines and complement factor H Y402H polymorphism in patients with dry age-related macular degeneration. Am J Ophthalmol 2013;156:1176–1183.
  • Kaemmerer E, Schutt F, Krohne TU, Holz FG, Kopitz J. Effects of lipid peroxidation-related protein modifications on RPE lysosomal functions and POS phagocytosis. Invest Ophthalmol Vis Sci 2007;48:1342–1347.
  • Vives-Bauza C, Anand M, Shirazi AK, Magrane J, Gao J, Vollmer-Snarr HR, et al. The age lipid A2E and mitochondrial dysfunction synergistically impair phagocytosis by retinal pigment epithelial cells. J Biol Chem 2008;283:24770–24780.
  • Michael P. Corcoran, Mohsen Meydani, Alice H. Lichtenstein et al. Sex hormone modulation of proinflammatory cytokine and CRP expression in macrophages from older men and postmenopausal women. Endocrinol 2010;206:217–224.
  • Bucolo C, Drago F, Lin LR, Reddy VN. Neuroactive steroids protect retinal pigment epithelium against oxidative stress. Neuro Rep 2005;16:1203–1207.
  • Ulaş F, Balbaba M, Özmen S, Çelebi S, Doğan Ü. Association of dehydroepiandrosterone sulfate, serum lipids, C-reactive protein and body mass index with age-related macular degeneration. Int Ophthalmol 2013;33:485–491.
  • Ausmanas MK, Tan DA, Jaisamrarn U, Tian XW, Holinka CF. Estradiol, FSH and LH profiles in nine ethnic groups of postmenopausal Asian women: the Pan-Asia Menopause (PAM) study. Climacteric 2007;10:427–437.
  • Longcope C, Franz C, Morello C, Baker R, Johnston CC. Steroid and gonadotropin levels in women during the peri-menopausal years. Maturitas 1986;8:189–196.
  • Song SJ, Youm DJ, Chang Y, Yu HG. Age-related macular degeneration in a screened South Korean population: prevalence, risk factors, and subtypes. Ophthalmic Epidemiol 2009;16:304–310.
  • Klein R, Knudtson MD, Cruickshanks KJ, Klein BE. Further observations on the association between smoking and the long-term incidence and progression of age-related macular degeneration: the Beaver Dam Eye Study. Arch Ophthalmol 2008;126:115–121.
  • Fraser-Bell S, Wu J, Klein R, Azen SP, Varma R. Smoking, alcohol intake, estrogen use, and age-related macular degeneration in Latinos: the Los Angeles Latino Eye Study. Am J Ophthalmol 2006;141:79–87.
  • Vingerling JR, Dielemans I, Hofman A, Grobbee DE, Hijmering M, Kramer CF, et al. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology 1995;102:205–210.
  • Smith W, Mitchell P, Leeder SR, Wang JJ. Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy: the Blue Mountains Eye Study. Arch Ophthalmol 1998;116:583–587.
  • Schaumberg DA, Christen WG, Hankinson SE, Glynn RJ. Body mass index and the incidence of visually significant ARMD in men. Arch Ophthalmol 2001;119:1259–1265.
  • Age-Related Eye Disease Study Research Group. Risk factors associated with age-related macular degeneration: a case-control study in the age-related eye disease study: age-related eye disease study report number 3. Ophthalmology 2000;107:2224–2232.
  • Klein BE, Klein R, Lee KE, Jensen SC. Measures of obesity and age-related eye diseases. Ophthalmic Epidemiol 2001;8:251–262.
  • Gambacciani M, Ciaponi M, Cappagli B, De Simone L, Orlandi R, Genazzani AR. Prospective evaluation of body weight and body fat distribution in early postmenopausal women with and without hormonal replacement therapy. Maturitas 2001;39:125–132.
  • Nowak M, Swietochowska E, Marek B, Szapska B, Wielkoszynski T, Kos-Kudla B, et al. Changes in lipid metabolism in women with age-related macular degeneration. Clin Exp Med 2005;4:183–187.
  • Tan JS, Mitchell P, Smith W, Wang JJ. Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology 2007;114:1143–1150.
  • Mulero J, Manresa N, Zafrilla P, Losada M. Markers of cardiovascular risk in elderly patients with age-related macular degeneration. Clin Hemorheol Microcirc 2014;58:447–453.
  • Millen AE, Voland R, Sondel SA, Parekh N, Horst RL, Wallace RB, et al. Vitamin D status and early age-related macular degeneration in postmenopausal women. Arch Ophthalmol 2011;129:481–489.
  • Singh A, Falk MK, Subhi Y, Sørensen TL. The association between plasma 25-hydroxyvitamin D and subgroups in age-related macular degeneration: a cross-sectional study. PLoS One 2013;8:e70948. doi:10.1371/journal.pone.0070948.
  • Wu W, Weng Y, Guo X, Feng L, Xia H, Hiang Z, Lou J. The association between serum vitamin D levels and age-related macular degeneration: a systematic meta-analytic review. Invest Ophthalmol Vis Sci 2016;57:2168–2177.
  • Fliesler SJ, Bretillon L. The ins and outs of cholesterol in the vertebrate retina. J Lipid Res 2010;51:3399–3413.
  • Schnatz PF, Jiang X, Vila-Wright S, Aragaki AK, Nudy M, O’Sullivan DM, et al. Calcium/vitamin D supplementation, serum 25-hydroxyvitamin D concentrations, and cholesterol profiles in the Women’s Health Initiative calcium/vitamin D randomized trial. Menopause 2014;21:823–833.
  • Toops KA, Tan LX, Jiang Z, Radu RA, Lakkaraju A. Cholesterol-mediated activation of acid sphingomyelinase disrupts autophagy in the retinal pigment epithelium. Mol Biol Cell 2015;26:1–14.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.